They poison cells that express the telomerase enzyme which indicates cancerous activity. The drug treatment is called Thio. 90% of cancers express telomerase enzyme.

Brian Wang interviewed Antiaging expert Aubrey de Grey. Aubrey told Nextbigfuture that his favorite company and approach for a broadly applicable treatment for cancer is at Maia Biotechnology.

He calls THIO "by far the most promising universal anti-cancer drug ever brought to the market"

Maia is using a telomere approach. THIO is a potentially first-in-class small molecule that is the only direct telomere targeting agent currently in clinical development. Telomerase is present in over 85% of human cancers and contributes significantly to the proliferation and reproductive immortality of cancer cells. THIO's in vitro activity has been studied in models of several tumor types with active telomerase.